Baylor College of Medicine - Molecular Virology and Microbiology

Houston, Texas 77030-3411

0 studies enrolling now · 33 studies all time

What they study most

Avian Influenza, Bacillus Anthracis (Anthrax), COVID-19, Chikungunya Virus Infection, Coronavirus (SARS-CoV), Cytomegalovirus Infections, Diphtheria, Gastroenteritis Norovirus, Influenza, Influenza Immunisation, Pertussis, Plasmodium Falciparum Malaria

Studies at this site

• Adaptive COVID-19 Treatment Trial 4 (ACTT-4) — Completed
• Adaptive COVID-19 Treatment Trial (ACTT) — Completed
• Adaptive COVID-19 Treatment Trial 3 (ACTT-3) — Completed
• Adaptive COVID-19 Treatment Trial 2 (ACTT-2) — Completed
• 2013/2017 H7N9 Prime-Boost Interval — Completed
• 2017 A/H7N9 IIV Revaccination — Completed
• Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza — Completed
• Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally — Completed
• Phase I Trial of Measles Vectored Chikungungya Vaccine — Completed
• Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine — Completed
• H5N1 With or Without Topical Aldara in Healthy Adults — Completed
• H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults — Completed
• H7N9 Boost in Healthy Adults — Completed
• gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females — Completed
• H7N9 Mix and Match With AS03 and MF59 in Healthy Adults — Completed
• Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Pediatric Populations — Completed
• H7N9 Mix and Match With MF59 in Healthy Elderly Persons — Completed
• A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults — Completed
• A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine — Completed
• H5N1 (Clade 2) Vaccination of Adults and Elderly — Completed
• Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE® — Completed
• Phase II Tularemia Vaccine Comparison — Completed
• Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels — Completed
• 2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women — Completed
• Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules — Completed
• Pertussis Vaccine in Healthy Pregnant Women — Completed
• Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule — Completed
• New Challenge Pool of Norwalk Virus Inoculum — Completed
• Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations — Completed
• Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly — Completed
• H5N1 Mix and Match With AS03 — Completed
• SARS Coronavirus Vaccine (SARS-CoV) — Withdrawn before enrolling
• Influenza Vaccine in Pregnant Women — Completed